Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
Current therapy for toxoplasmosis with a synergistic combination of pyrimethamine plus sulfadiazine or pyrimethamine plus clindamycin is not always efficacious and is frequently discontinued due to intolerable toxic effects in immunocompromised individuals, particularly those with AIDS. Trovafloxaci...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1997
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9145840/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.5.893 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
